Systemic copper pool and copper-dependent enzymes

The systemic copper pool and copper-dependent enzymes represent the collective regulatory system for copper homeostasis in the human body. Copper is an essential trace element that serves as a critical cofactor for various cuproenzymes, including cytochrome c oxidase for energy production, superoxide dismutase for antioxidant defense, and lysyl oxidase for cross-linking collagen and elastin [StatPearls, Copper Toxicity]. Dysregulation of this pool leads to severe pathologies: Wilson disease involves toxic copper accumulation due to ATP7B mutations, while Menkes disease results from systemic deficiency due to ATP7A mutations [NIH, Wilson Disease]. Pharmacological intervention typically involves copper chelators like penicillamine or trientine to remove excess metal or zinc salts to inhibit intestinal absorption [PubMed, Copper Chelation Therapy]. Recently, the concept of "cuproptosis"—a form of regulated cell death triggered by copper accumulation—has emerged as a novel therapeutic strategy in oncology using copper ionophores like elesclomol [Science, 2022]. Maintaining the delicate balance of the systemic copper pool is vital, as both deficiency and toxicity can lead to irreversible neurological and hepatic damage. Monitoring of this system is typically performed through biomarkers such as serum ceruloplasmin and non-ceruloplasmin bound copper levels.

Other names

Copper homeostasis systemCuproenzymesLabile copper poolCellular copper poolCopper metabolism

Drugs targeting the systemic copper pool primarily act through chelation to facilitate urinary excretion of excess copper, induction of endogenous metallothioneins to block intestinal copper absorption, or via ionophores that transport copper into specific cells to trigger copper-dependent cell death pathways (cuproptosis).